3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
47
Radiotherapy
37
Fluorouracil
23
Cetuximab
17
pembrolizumab
11
Carboplatin
11
Paclitaxel
8
Docetaxel
8
Radiotherapy, Intensity-Modulated
6
Chemotherapy, Adjuvant
6
Surgical Procedures, Operative
5
Standard of Care
5
nimotuzumab
4
Methotrexate
4
Gabapentin
4
Drug Therapy
4
Afatinib
4
Radiotherapy, Conformal
3
Radiation
3
Porfiromycin
3
Nivolumab
3
Neoadjuvant Therapy
3
Fibroblast Growth Factor 7
3
Bleomycin
3
zalutumumab
2
sargramostim
2
epacadostat
2
Tranexamic Acid
2
Tirapazamine
2
Pilocarpine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Head and Neck Neoplasms
×
monalizumab
×
Clear all
NCT04590963
2026-06-01
INTERLINK-1
AstraZeneca
Phase 3
Active not recruiting
370 enrolled
21 charts